Close the acquisition of Cerevel Therapeutics
Delivered after the deadline (32 days after the deadline)
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 6 Dec 2023
- Due
- 30 Jun 2024
- Delivered
- 1 Aug 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“This transaction is expected to close in the middle of 2024, subject to Cerevel shareholder approval, regulatory approvals, and other customary closing conditions.”
What we found
Evidence strength A What the grades mean
AbbVie completed the acquisition of Cerevel Therapeutics on August 1, 2024, which occurred after the stated mid-2024 deadline.
-
A AbbVie Inc. 10-Q filed 2024-11-04
“On August 1, 2024, AbbVie completed its previously announced acquisition of Cerevel Therapeutics.” ✓ confirmed on the page
Market reaction: the shares moved -4.7% against the S&P 500 over the three sessions around the disclosure (1 Nov 2024 to 6 Nov 2024). What this measures
Checked 5 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- Acquisition of Cerevel Therapeutics
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: Cerevel shareholder approval; regulatory approvals; customary closing conditions
- Depends on
- Regulatory, Shareholder
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you AbbVie Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-ABBV-004804 · Corrections policy